Posts by: Carolina Henriques

Carolina Henriques

Carolina holds a BSc in Anthropology and a MSc in Urban Studies., and brings her interdisciplinary skills to her writing on a range of different topics in science, research and advocacy news.

March 14, 2016March 16, 2016

RespirTech Introduces Cystic Fibrosis Treatment Remote Monitoring System

Bronchiectasis, COPD, Cystic Fibrosis, News

RespirTech, an important provider of airway clearance therapy vests, is developing an innovative way for clinicians to remotely monitor the treatment of cystic fibrosis (CF) patients, funded by a Small Business Innovation Research (SBIR) ... Read more

March 11, 2016May 13, 2016

For Idiopathic Pulmonary Fibrosis, NuQ Blood Test a Promising Diagnostic Tool

Idiopathic Pulmonary Fibrosis, News

VolitionRx, dedicated to the development of blood-based diagnostic tests, recently announced preliminary data from a pilot study showing that its blood test NuQ successfully detected 86 percent of patients with ... Read more

March 10, 2016March 16, 2016

Nivalis Expands Clinical Development of Its Cystic Fibrosis CFTR Stabilizer

Cystic Fibrosis, News

Nivalis Therapeutics recently announced the expansion of the clinical development plan for N91115, the company’s investigational, first-in-class stabilizer of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, which is defective in ... Read more

March 9, 2016March 16, 2016

Better Lives for Cystic Fibrosis Patients Is Focus of £750,000 Grant for Physical Activity, Exercise Programs

Cystic Fibrosis, News

A renowned team of international specialists at the University of Exeter in England was awarded a grant of £750,000 from the Cystic Fibrosis Trust to develop an inclusive strategy to allow young people who ... Read more

March 8, 2016May 13, 2016

Lung Institute Opens Stem Cell Therapy Clinic in Dallas for Patients with Chronic Lung Diseases

COPD, Idiopathic Pulmonary Fibrosis, News

A top provider of stem cell therapy research for lung conditions, the Lung Institute, recently announced its new location, close to the metro Dallas area in Texas. The Institute has also ... Read more

March 7, 2016March 7, 2016

Therabron Announces New Program to Enhance Lung Health at 2016 Conference

COPD, News

Therabron Therapeutics recently presented a study titled “Modification of CC10 Protein by Reactive Oxygen Species (ROS) during Acute Lung Injury” that introduces a program designed to develop several novel isoforms of ... Read more

March 7, 2016March 16, 2016

Savara Preparing Clinical Trial on Lung Infection Therapy for CF After Completing $20M Round of Financing

Cystic Fibrosis, News

Austin, Texas-based Savara Pharmaceuticals, a company focused on novel drugs for the treatment of rare respiratory diseases, recently announced the completion of a $20 million Series C round of financing. The ... Read more

March 2, 2016May 13, 2016

Lung Cancer in Women Research Gets $250,000 from Newly-Founded Momentum Research Award

Lung Cancer, News

The Bonnie J. Addario Lung Cancer Foundation (ALCF), together with the American Lung Association (ALA), collaborated to launch a new research award to fund innovative research in clinical diagnostic and treatment options for lung ... Read more

March 1, 2016May 13, 2016

Lives of Asthmatic Children Eased With ‘Meds-in-Hand’ Hospital Collaborative Program

News

Boston Medical Center (BMC) physician and pharmacist researchers recently published a new study in which they highlighted the “Meds-in-Hand” program, which was established when doctors realized their pediatric asthma patients who left ... Read more

February 29, 2016May 13, 2016

Ofev (Nintedanib) Slows IPF Disease Progression, According to Analysis of Studies

Idiopathic Pulmonary Fibrosis, News

An analysis of the Phase II TOMORROW trial and two Phase III INPULSIS trials (INPULSIS-1 and INPULSIS-2), analyzing the safety and efficacy outcomes for Ofev (nintedanib, developed by Boehringer Ingelheim), revealed that ... Read more